Global trends on fears and concerns of genetic discrimination: a systematic literature review

Since the 1990s, developments in the field of genetics have led to many questions on the use and possible misuse of genetic information. ‘Genetic discrimination’ has been defined as the differential treatment of asymptomatic individuals or their relatives on the basis of their real or assumed genetic characteristics. Despite the public policy attention around genetic discrimination, there is currently still much confusion surrounding this phenomenon. On the one hand, there is little evidence of the occurrence of genetic discrimination. On the other hand, it appears that people remain concerned about this theme, and this fear influences their health and life choices. This article makes use of a systematic literature review to investigate what is already known about the nature, extent and background of these fears and concerns. The 42 included studies have found considerable levels of concerns about genetic discrimination. Concerns dominate in insurance contexts and within personal interactions. The extent of concerns appears to vary depending on the type of genetic illness. Furthermore, installed laws prohibiting genetic discrimination do not seem to alleviate existing fears. This raises important questions as to the origins of these fears. Based on the findings, recommendations for future research are made. First, research on the background of fears is needed. Second, future research needs to assess more fully all different forms (for example, direct and indirect) of genetic discrimination. Thirdly, it has to be studied whether genetic discrimination is a form of discrimination that is distinguishable from discrimination based on an illness or disability. Finally, a last element that should be addressed in future research is the most recent developments in research on genomics, such as next-generation sequencing or genome-wide association studies.

[1]  R. Zinberg,et al.  Referral and experience with genetic testing among women with early onset breast cancer. , 2005, Genetic testing.

[2]  B. Bernhardt,et al.  Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia , 2011, Genetics in Medicine.

[3]  J. Bernat,et al.  Ethical, social and legal implications of genetic testing in liver disease , 2006, Hepatology.

[4]  M. Sawicki,et al.  Human Genome Project. , 1993, American journal of surgery.

[5]  S. Chandrasekharan,et al.  Spinocerebellar ataxia: Patient and health professional perspectives on whether and how patents affect access to clinical genetic testing , 2010, Genetics in Medicine.

[6]  W. Nowlan.  A Rational View of Insurance and Genetic Discrimination , 2002, Science.

[7]  B. Bernhardt,et al.  Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients , 2004, Genetics in medicine : official journal of the American College of Medical Genetics.

[8]  N. Holtzman,et al.  Toward a Model Informed Consent Process for BRCA1 Testing: A Qualitative Assessment of Women's Attitudes , 1997, Journal of Genetic Counseling.

[9]  M R Natowicz,et al.  Genetic discrimination and the law. , 1992, American journal of human genetics.

[10]  T. Lemke.  "A slap in the face". An exploratory study of genetic discrimination in Germany , 2009, Genomics, society, and policy.

[11]  L. Gostin,et al.  Access to health insurance: Experiences and attitudes of those with genetic versus non‐genetic medical conditions , 2007, American journal of medical genetics. Part A.

[12]  E. Thomson,et al.  Concerns in a primary care population about genetic discrimination by insurers , 2005, Genetics in Medicine.

[13]  M R Natowicz,et al.  Discrimination as a consequence of genetic testing. , 1992, American journal of human genetics.

[14]  P. Tonin,et al.  A descriptive study of BRCA1 testing and reactions to disclosure of test results , 1997, Cancer.

[15]  Jane S. Paulsen,et al.  Perception, experience, and response to genetic discrimination in Huntington disease: The international RESPOND‐HD study , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[16]  P. Barton,et al.  Experiences and attitudes concerning genetic testing and insurance in a Colorado population: a survey of families diagnosed with fragile X syndrome. , 1996, American journal of medical genetics.

[17]  N. Wake,et al.  Chromosomes and causation of human cancer and leukemia. XLIV. A method for chromosome analysis of solid tumors. , 1981, Cancer genetics and cytogenetics.

[18]  Gail Geller,et al.  Mapping the human genome: An assessment of media coverage and public reaction , 2002, Genetics in Medicine.

[19]  Unjustified Discrimination: Is the Moratorium on the use of Genetic Test Results by Insurers a Contradiction in Terms? , 2010, Health Care Analysis.

[20]  Y. Bombard,et al.  Genetic discrimination: international perspectives. , 2012, Annual review of genomics and human genetics.

[21]  Y. Joly,et al.  Genetic discrimination in private insurance: global perspectives , 2010 .

[22]  A. Polglase,et al.  Factors Influencing Uptake of Genetic Testing For Colorectal Cancer Risk in an Australian Jewish Population , 2005, Journal of Genetic Counseling.

[23]  Emily White,et al.  Genetic Testing for Cancer Risk: A Population Survey on Attitudesand Intention , 1999, Public Health Genomics.

[24]  N. Robin,et al.  Attitudes of African American premedical students toward genetic testing and screening , 2003, Genetics in Medicine.

[25]  B. Bernhardt,et al.  Utilization of BRCA1/2 genetic testing in the clinical setting , 2002, Cancer.

[26]  R. Bennett,et al.  Survey of unaffected BRCA and mismatch repair (MMR) mutation positive individuals , 2009, Familial Cancer.

[27]  Jane S. Paulsen,et al.  Perception, experience, and response to genetic discrimination in Huntington's disease: the Australian results of The International RESPOND-HD study. , 2013, Genetic testing and molecular biomarkers.

[28]  D. Asch,et al.  Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination , 2003, American journal of medical genetics. Part A.

[29]  E. Oster,et al.  Fear of health insurance loss among individuals at risk for Huntington disease , 2008, American journal of medical genetics. Part A.

[30]  R. Klitzman,et al.  Views of Discrimination among Individuals Confronting Genetic Disease , 2010, Journal of Genetic Counseling.

[31]  M. Ropka,et al.  Factors Influencing Patients' Decisions to Decline Cancer Genetic Counseling Services , 2001, Journal of Genetic Counseling.

[32]  J. Garber,et al.  A population-based study of Ashkenazi Jewish women’s attitudes toward genetic discrimination and BRCA1/2 testing , 2002, Genetics in Medicine.

[33]  J. Quinlivan,et al.  What Factors Impact upon a Woman’s Decision to Undertake Genetic Cancer Testing? , 2014, Front. Oncol..

[34]  W. Meschino,et al.  Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2 , 2000, Clinical genetics.

[35]  S. Terry,et al.  Before It's Too Late--Addressing Fear of Genetic Information , 2002, Science.

[36]  S. Steinberg,et al.  Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. , 2003, Archives of internal medicine.

[37]  S. Merajver,et al.  Health Insurance and Discrimination Concerns and BRCA 1 / 2 Testing in a Clinic Population 1 , 2002 .

[38]  Torben Spaak.  Genetic Discrimination , 2019, Definitions.

[39]  C. Kozma,et al.  Genetic Discrimination: Perspectives of Consumers , 1996, Science.

[40]  S. Friedman,et al.  Consumer awareness and attitudes about insurance discrimination post enactment of the Genetic Information Nondiscrimination Act , 2012, Familial Cancer.

[41]  D. Wertz.  Genetic discrimination--an overblown fear? , 2002, Nature reviews. Genetics.

[42]  B. Knoppers,et al.  Life insurance: genomic stratification and risk classification , 2013, European Journal of Human Genetics.

[43]  Jane S. Paulsen,et al.  Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[44]  Emiliano De Cristofaro.  An Exploratory Ethnographic Study of Issues and Concerns with Whole Genome Sequencing , 2013, 1306.4962.

[45]  S. Taylor,et al.  A Population-Based Survey in Australia of Men’s and Women’s Perceptions of Genetic Risk and Predictive Genetic Testing and Implications for Primary Care , 2011, Public Health Genomics.

[46]  T. Lemke.  Perspectives on Genetic Discrimination , 2013 .

[47]  M. Petticrew,et al.  Systematic Reviews in the Social Sciences: A Practical Guide , 2005 .

[48]  D. Whitcomb,et al.  Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis , 2001, American Journal of Gastroenterology.

[49]  Jennifer L. Bevan,et al.  Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research. , 2005, Social science & medicine.

[50]  Y. Bombard,et al.  Beyond the patient: The broader impact of genetic discrimination among individuals at risk of Huntington disease , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[51]  G. Lenoir,et al.  An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. , 1999, Cancer genetics and cytogenetics.

[52]  W. D. Dotson,et al.  Public Awareness of Genetic Nondiscrimination Laws in Four States and Perceived Importance of Life Insurance Protections , 2015, Journal of Genetic Counseling.

[53]  T. Hoffmann,et al.  Cost effectiveness of patient education for the prevention of falls in hospital: economic evaluation from a randomized controlled trial , 2013, BMC Medicine.

[54]  M R Anderlik,et al.  Privacy and confidentiality of genetic information: what rules for the new science? , 2001, Annual review of genomics and human genetics.

[55]  J. Coyne,et al.  Factors associated with decisions about clinical BRCA1/2 testing. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  Jane S. Paulsen,et al.  Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease , 2008, European Journal of Human Genetics.

[57]  M. Roberts,et al.  Self Diagnosis of Lynch Syndrome Using Direct to Consumer Genetic Testing: A Case Study , 2011, Journal of Genetic Counseling.

[58]  Jane S. Paulsen,et al.  In their own words: Reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND‐HD study , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[59]  K. Horstman,et al.  Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts , 2012, European Journal of Human Genetics.

[60]  K. Armstrong,et al.  Attitudes and Misconceptions about Predictive Genetic Testing for Cancer Risk , 2005, Public Health Genomics.